NCT05573048
A Study of Optical Fusion Trans-Perineal Grid
Enrolling by Invitation
NAAges 45+InterventionalDevice feasibilityMayo ClinicInvestigator-initiated
~20 participants
Updated 2026-01-14 on ClinicalTrials.gov
What's tested:Trans-Perineal Grid
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Needle placement accuracy
Measured over Baseline
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- David Woodrum, MD, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Scheduled for a MR guided biopsy or ablation.
One, two, or three tumor suspicious regions identified on multiparametric MRI.
Tolerance for anesthesia/sedation.
Ability to give informed consent.
Exclusion
Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI.
History of other primary non-skin malignancy within previous three years.
What this trial measures
- Needle placement accuracyBaseline
Number of needle placements to successfully match target and needle tip position assessed by direct MR imaging and